FindTrial
Sign In

A STUDY TO KNOW THE EFFICACY AND FEASIBILITY OF SERUM LACTATE,TOTAL LEUCOCYTE COUNT AND NEUTROPHIL TO LYMPHOCYTE RATIO AS EARLY PREDICTORS OF PUERPERAL SEPSIS

A CROSS SECTIONAL STUDY TO EVALUATE THE EFFICACY AND FEASIBILITY OF SERUM LACTATE,TOTAL LEUCOCYTE COUNT AND NEUTROPHIL TO LYMPHOCYTE RATIO AS EARLY PREDICTORS OF PUERPERAL SEPSIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036455
Enrollment
210
Registered
2021-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

Shri BM Patil Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: LOW RISK GROUP-Spontaneous on set of labor delivery within 24hrs of onset of labor, cephalic presentation. HIGH RISK GROUP-induced labor, prolonged labor morethan 24hrs, prom, preterm labor,instrumental labor,aneamia.

Exclusion criteria

Exclusion criteria: pregnant women with PIH and GDM. Pregnant women with already established sepsis. patient undergoing caesarean section. pregnant women other than cephalic presentation. pregnant women with preexisting medical disorders. pregnant women on drugs like metformin, acetaminophen, linezolid, beta2agonists, which cause elevation of serum lactate.

Design outcomes

Primary

MeasureTime frame
TO KNOW THE CUTOFF LEVELS OF SERUM LACTATE ,TOTAL LEUCOCYTE COUNT AND NEUTROPHIL TO LYMHOCYTE RATIO AS A PREDICTOR OF PUERPERAL SEPSISTimepoint: 48 TO 72 HOURS—

Secondary

MeasureTime frame
TO KNOW THE DIFFERENCE IN THE PREDICTORS BETWEEN LOW RISK AND HIGH RISK CASESTimepoint: 48 TO 72 HOURS—

Countries

India

Contacts

Public ContactDrNEELAMMA PATIL

BLDE(DU) Shri BM Patil Medical College Hospital and Research Cente

patilneelgiri@rediffmail.com9845068074

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026